Deepa Rangachari

519 total citations
13 papers, 360 citations indexed

About

Deepa Rangachari is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Deepa Rangachari has authored 13 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 2 papers in Genetics. Recurrent topics in Deepa Rangachari's work include Lung Cancer Treatments and Mutations (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Lung Cancer Research Studies (4 papers). Deepa Rangachari is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Lung Cancer Research Studies (4 papers). Deepa Rangachari collaborates with scholars based in United States and Israel. Deepa Rangachari's co-authors include Daniel B. Costa, Kartik Sehgal, Page Widick, Ritu R. Gill, Meghan Shea, Richard D. Schulick, Daniel A. Laheru, Ralph H. Hruban, Timothy M. Pawlik and Stephen C. Yang and has published in prestigious journals such as Journal of Clinical Oncology, Blood and American Journal of Kidney Diseases.

In The Last Decade

Deepa Rangachari

11 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Deepa Rangachari United States	8	307	179	68	51	38	13	360
Robert S. Brody United States	6	269 0.9×	176 1.0×	92 1.4×	55 1.1×	55 1.4×	11	453
Enzo Veltri Italy	10	353 1.1×	150 0.8×	57 0.8×	61 1.2×	42 1.1×	13	421
Guoqin Qiu China	10	203 0.7×	164 0.9×	51 0.8×	69 1.4×	51 1.3×	23	325
Shiven B. Patel United States	12	276 0.9×	168 0.9×	36 0.5×	41 0.8×	31 0.8×	47	420
Hitomi Sumiyoshi Okuma Japan	11	209 0.7×	109 0.6×	66 1.0×	67 1.3×	23 0.6×	53	336
Cuiling Zhou China	10	253 0.8×	143 0.8×	119 1.8×	48 0.9×	29 0.8×	11	404
Lucia Bonomi Italy	8	256 0.8×	220 1.2×	29 0.4×	36 0.7×	18 0.5×	23	433
Munehiro Ito Japan	8	481 1.6×	317 1.8×	28 0.4×	31 0.6×	54 1.4×	14	541
Jiewen Peng China	8	242 0.8×	90 0.5×	168 2.5×	130 2.5×	48 1.3×	12	471
Franco Vito Piantedosi Italy	12	519 1.7×	432 2.4×	76 1.1×	124 2.4×	46 1.2×	14	698

Countries citing papers authored by Deepa Rangachari

Since Specialization

Citations

This map shows the geographic impact of Deepa Rangachari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deepa Rangachari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deepa Rangachari more than expected).

Fields of papers citing papers by Deepa Rangachari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deepa Rangachari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deepa Rangachari. The network helps show where Deepa Rangachari may publish in the future.

Co-authorship network of co-authors of Deepa Rangachari

This figure shows the co-authorship network connecting the top 25 collaborators of Deepa Rangachari. A scholar is included among the top collaborators of Deepa Rangachari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deepa Rangachari. Deepa Rangachari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Pineda, Cristiana M., Benjamin Heyman, Deepa Rangachari, et al.. (2025). Patterns of HER2 expression and genomic correlates in lung cancer, with a focus on preanalytical variables impacting immunohistochemical staining results. Journal of Clinical Pathology. 79(1). 24–30. 1 indexed citations

Widick, Page, et al.. (2025). Real world efficacy of dose-reduced capmatinib and tepotinib for advanced MET exon 14–skipping+ NSCLC.. Journal of Clinical Oncology. 43(16_suppl).

Meador, Catherine B., Subba R. Digumarthy, Beow Y. Yeap, et al.. (2022). Phase I/II investigator-initiated study of olaparib and temozolomide in SCLC: Updated analysis and CNS outcomes.. Journal of Clinical Oncology. 40(16_suppl). 8565–8565. 3 indexed citations

Sehgal, Kartik, Ritu R. Gill, Page Widick, et al.. (2021). Association of Performance Status With Survival in Patients With Advanced Non–Small Cell Lung Cancer Treated With Pembrolizumab Monotherapy. JAMA Network Open. 4(2). e2037120–e2037120. 100 indexed citations

Kobayashi, Ikei S., Hollis Viray, Deepa Rangachari, Susumu Kobayashi, & Daniel B. Costa. (2021). EGFR-D770>GY and Other Rare EGFR Exon 20 Insertion Mutations with a G770 Equivalence Are Sensitive to Dacomitinib or Afatinib and Responsive to EGFR Exon 20 Insertion Mutant-Active Inhibitors in Preclinical Models and Clinical Scenarios. Cells. 10(12). 3561–3561. 11 indexed citations

Sehgal, Kartik, Daniel B. Costa, & Deepa Rangachari. (2020). Extended-Interval Dosing Strategy of Immune Checkpoint Inhibitors in Lung Cancer: Will it Outlast the COVID-19 Pandemic?. Frontiers in Oncology. 10. 1193–1193. 19 indexed citations

Leaf, Rebecca Karp, Deepa Rangachari, James W. Mier, et al.. (2019). Clinical and laboratory features of autoimmune hemolytic anemia associated with immune checkpoint inhibitors. American Journal of Hematology. 94(5). 563–574. 49 indexed citations

Petri, Camille R., Rushad Patell, Felipe Batalini, Deepa Rangachari, & Robert W. Hallowell. (2019). Severe pulmonary toxicity from immune checkpoint inhibitor treated successfully with intravenous immunoglobulin: Case report and review of the literature. Respiratory Medicine Case Reports. 27. 100834–100834. 30 indexed citations

Leaf, Rebecca Karp, Kerry L. Reynolds, Deepa Rangachari, et al.. (2018). Clinical Features of Immune Checkpoint Inhibitor-Associated Autoimmune Hemolytic Anemia: A Series of 14 Cases. Blood. 132(Supplement 1). 1037–1037.

10.

Le, Xiuning, Neelam V. Desai, Adnan Majid, et al.. (2015). De novo pulmonary small cell carcinomas and large cell neuroendocrine carcinomas harboring EGFR mutations: Lack of response to EGFR inhibitors. Lung Cancer. 88(1). 70–73. 23 indexed citations

11.

Rangachari, Deepa & Julie R. Brahmer. (2013). Targeting the Immune System in the Treatment of Non-Small-Cell Lung Cancer. Current Treatment Options in Oncology. 14(4). 580–594. 12 indexed citations

12.

Storm, Andrew C., Bhavna Bhasin, Deepa Rangachari, & C. John Sperati. (2013). Quiz Page January 2014. American Journal of Kidney Diseases. 63(1). A18–A21. 3 indexed citations

13.

Arnaoutakis, George J., Deepa Rangachari, Daniel A. Laheru, et al.. (2011). Pulmonary Resection for Isolated Pancreatic Adenocarcinoma Metastasis: an Analysis of Outcomes and Survival. Journal of Gastrointestinal Surgery. 15(9). 1611–1617. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact